SYK · News · 20261001N

Manufacturing And Capacity

STRYKER CORP · 2026-10-01 · Importance 40 · Surprise 42 · In source text

Stryker’s Peripheral Vascular unit, acquired through Inari Medical, is experiencing a manufacturing issue that has persisted beyond the previously expected resolution timeline. The problem is now expected to continue into the fourth quarter of 2026, rather than being resolved by the end of the third quarter. Third-party reporting indicates the disruption is affecting sales and new business opportunities in the peripheral vascular market.

Key facts

• The CFO revealed that the manufacturing problem would continue into Q4, contradicting earlier statements that it would be resolved by the end of Q3. source
• Stryker will host a webcast on Thursday, October 29, 2026, at 4:30 p.m. Eastern time to discuss its third quarter 2026 financial results. source
• An accompanying press release with summary financial information will be issued at 4:05 p.m. Eastern time on October 29, 2026. source
• Stryker reported Q2 2026 revenues of $6.59 billion and adjusted EPS of $3.69, exceeding consensus estimates. source
• Stryker demonstrates at least 8% revenue growth, according to an article highlighting AI-driven healthcare stocks. source
• The manufacturing issue in Stryker's Peripheral Vascular unit, acquired through Inari Medical, is persisting longer than initially assured. source
• Stryker provides products and services in MedSurg, Neurotechnology, and Orthopaedics. source

Impact estimates